BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22887176)

  • 21. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
    Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
    World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
    Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
    Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of splenic marginal zone lymphoma.
    Kennedy ND; Lê GN; Kelly ME; Harding T; Fadalla K; Winter DC
    Ir J Med Sci; 2018 May; 187(2):343-347. PubMed ID: 29043543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
    de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
    BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.
    Pata G; Damiani E; Bartoli M; Solari S; Anastasia A; Pagani C; Tucci A; Ragni F
    Leuk Lymphoma; 2016; 57(6):1467-70. PubMed ID: 26373930
    [No Abstract]   [Full Text] [Related]  

  • 27. Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
    Florindez JA; Alderuccio JP; Reis IM; Lossos IS
    Cancer; 2020 Nov; 126(21):4706-4716. PubMed ID: 32767702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini RM
    Br J Haematol; 2021 Aug; 194(3):568-579. PubMed ID: 34109612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.
    Montalbán C; Abraira V; Arcaini L; Domingo-Domenech E; Guisado-Vasco P; Iannitto E; Mollejo M; Matutes E; Ferreri A; Salar A; Rattotti S; Carpaneto A; Pérez Fernández R; Bello JL; Hernández M; Caballero D; Carbonell F; Piris MA;
    Br J Haematol; 2012 Oct; 159(2):164-71. PubMed ID: 22924582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Kontopidou FN; Yiakoumis X; Kokoris SI; Dimitriadou EM; Dimopoulou MN; Moschogiannis M; Korkolopoulou P; Kyrtsonis MC; Siakantaris MP; Papadaki T; Tsaftaridis P; Plata E; Papadaki HE; Vassilakopoulos TP
    Oncologist; 2013; 18(2):190-7. PubMed ID: 23345547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
    Riccioni R; Caracciolo F; Galimberti S; Cecconi N; Petrini M
    Hematol Oncol; 2003 Dec; 21(4):163-8. PubMed ID: 14735554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
    Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
    Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic marginal zone lymphoma.
    Oscier D; Owen R; Johnson S
    Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of marginal zone lymphoma.
    Reid R; Friedberg JW
    Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
    [No Abstract]   [Full Text] [Related]  

  • 38. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A peculiar case of splenic marginal zone lymphoma and review of literature.
    Mishra MN; Pandey R; Dinda A; Nityanand S
    Iran J Immunol; 2013 Sep; 10(3):186-9. PubMed ID: 24076596
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.